Table Of Content. EURORDIS_FY Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7
|
|
- Francis Mills
- 6 years ago
- Views:
Transcription
1 Table Of Content EURORDIS_FY Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D04 - Electronic Newsletter and V.3 of EURORDIS website (EN)... 7 D01 - Activity Report OPERA (EN)... 7 D B.1.b. Annexe 1.Report CNA meeting 13 May 2010 (EN)... 7 D B.1.b. Annexe 2.Report CNA Meeting 12 December 2010 (EN)... 7 D B.1.c. Annexe 1.3rd CEF Workshop - Report (EN)... 7 D B.1.c. Annexe 2.Support EF terms&conditions (EN)... 7 D B.1.d. B.1.d. Annexe 1 (EN)... 7 D03 - Update of EURORDIS RD community Database (EN)... 7 D05 - Summer School 2010 and online (EN)... 7 D06 - Online patients and advocates community portal (EN)... 7 D07 - Meetings of the Task Forces Orphan Drugs, DITA and Paediatrics (EN)... 7 D08 - Participation in EMEA Committees (COMP, PDCO, CAT, PCWP) and update through the TAG (EN)... 7 D09 - Rare Disease Day 2010 (EN)... 7 Final Report (EN)... 7 Page 1/10
2 EURORDIS_FY2010 JA GPSD [705038] START DATE: 01/01/2010 END DATE: 01/01/2011 DURATION: 12 month(s) CURRENT STATUS: Finalised PROGRAMME TITLE: Second Programme of Community action in the Field of Health PROGRAMME PRIORITY: - CALL: Promote Health (Hp-2009) TOPIC: PROMOTE HEALTH (HP-2009) EC CONTRIBUTION: EUR KEYWORDS: Accessibility, Health system, Pharmaceuticals, Rare diseases and disorders, Survey PORTFOLIO: Interest groups, Rare diseases Page 2/10
3 SUMMARY Mission and vision of the operating grant holder EURORDIS is a patient-driven alliance of Patient Organisations (POs) and individuals active in the field of rare diseases (RD). It represents the voice of an estimated 29 million citizens in the EU. EURORDIS mission is to build a strong pan-european community of POs and People Living With RD (PLWRD), to be their voice at the European level and to fight against the impact of RD on their lives. To this end, EURORDIS undertakes activities on behalf of its members, notably in favour of: Empowering RD patient groups Advocating RD as a public health priority Raising public awareness on RD (national and international levels) Improving access to information, treatment, care and support for PLWRD, including support to families Improving quality of life Encouraging good practices in relation to these issues Promoting scientific and clinical research on RD Developing treatments and drugs for people with RD EURORDIS plays a pivotal role in the definition and implementation of the EU strategy on RD (EC Communication, Dec.2008 and Council Recommendations, June 2009). Strategic objectives and specific activities The following objectives are based on EURORDIS strategic approach : 1. To make RD a priority visible on the EU agenda: -Promote RD as a PH priority at EU and national levels -Organise the European Conference on Rare Diseases (ECRD) every 2 years (Luxembourg, Lisbon, Cracow) -Promote a specific EU policy framework: Commission Communication & Council Recommendation on RD -Promote national plans on RD -Focus on key EU public policy issues relevant to PLWRD -Promote RD as global PH priority and international networking -Raise awareness through annual Rare Disease Day (RDD) 2. To consolidate and empower the RD patient community: -Enhance communication with RD groups, members or not -Broaden the patient group membership base -Maintain focus on new and future MS -Organise the annual Membership meeting Page 3/10
4 -Bring the network of national alliances to a more active level -Create the network of EU disease specific Federations -Revamp the EURORDIS Website -Identify, involve and support volunteers in more activities -Organise capacity building & training sessions for patient representatives 3. To shape the EU environment for better information,care and drug development: -Shift priorities toward more PH activities and services to patients: Promote access to quality care, information & support services -Focus therapy activity on development and access to OD, paediatrics & ATMPs Participate in EMEA Committees & link-in patient expertise Facilitate dialogue between patient groups,experts,companies & regulators Improve access to RD therapies, incl. challenges of HTA in RD Inform and involve more members/volunteers in therapeutic activities -Address bottlenecks toward therapies through patient driven EU research infrastructures (biobanks, patient databases & registries, clinical trials) -Bridge the gap between patient needs and research policy in biomedicine, PH, social & ethics 4. To achieve cross cutting priorities: -Perform EURORDIS Strategic Review Include web communication in all activities -Develop office support services -Increase EU support to our projects and other RD activities -Diversify resources incl. fund raising events (Gala Dinner 2010 Brussels) Expected outcomes A. Communication and information to POs, stakeholders and the public: a) EURORDIS Website & Electronic newsletter in 6 languages b) Activity Report, brochures; update of main reference documents on RD; translation c) European RDD 2010 on 28/02 and Media Monitoring Services d) Awareness video & photo contest e) Maintenance of EURORDIS RD community databases: 1200 POs, 374 members, 150 volunteers; f) Strengthening support to more volunteers representing EURORDIS in EU committees g) Strengthening international dialogue with eg. ICORD, NORD, CORD, DIA, etc B. Capacity building for patient representatives: 1. Health Policy, POs networking and empowerment: a) Outreach to POs and members, dissemination of information, consultation of members, focus on new MS incl. fellowships b) Support the EU Network of National Alliances; organisation of 2 Workshops of the Council of National Alliances(CNA); involvement in public awareness and empowerment on the development of strategies for RD at national level c) Support and strengthen the Network of EU RD specific Federations; organisation of 1 Workshop for the Council of European Federations(CEF); support the creation of EU Page 4/10
5 RD Federations through experience sharing and good practices on wiki tool(wiki guide); involvement in public awareness and empowerment on EU policies(ex: CoE, ERN) d) Fact sheets on RD topics and policy aspects for capacity-building purposes. 2. Support and Information services to patients: a) Stimulate development and improve access to 1)Respite Care Services 2)Therapeutic Recreation Programmes through fact sheets, site visits, promotional activities and maintenance of online information resources widely available to the public b) Support and strengthen the EU Network of RD Help Lines through: - membership procedure - sharing tools and 6 visits or capacity building sessions for national help lines - 2 meetings of Steering Committee and 1 European Workshop c) Support the development of Online Patients Communities services with web interactive tools; recruit, train and support moderators; promote the service and each community. 3. Research and Therapeutics Development: a) Patient involvement in EMEA activities: - Support the participation of patient representatives in the EMEA Committees (COMP, PDCO, CAT, PCWP) and in protocol assistance - Support the EURORDIS Therapeutic Advisory Group(TAG)composed of all RD patient representatives in EMEA activities to exchange information and coordinate activities; - Monthly report compiling feedback from each committee. b) Review and validate public information on RD therapies disseminated by the EMEA at the time of designation (PSOs) and marketing authorisation (EPARs, Package Leaflet(PL)). c) Support involvement of more RD patient representatives in the OD,PD, ATMP policies and in drug development through information dissemination and capacity building activities on clinical trials and EU regulatory affairs, using the following means: - Support EURORDIS Task Forces on Orphan Drugs, Paediatrics, Drug Information,Transparency & Access (DITA), each involving trained volunteers; - Summer School 2010: build on previous training sessions( ) for the 2010 session (60 participants) based on experience exchange & case studies - Development of e-learning on specific and advanced aspects of drug development, clinical trials and regulatory affairs d) Support capacity building activities of patient advocates in HTA through a section on the website, dissemination of information, financing 10 fellows to participate in training for professionals (ex: DIA Forum on HTA) and initiation session on HTA in the Summer School 2010; e) Support good practice relations between POs & Sponsors on RD CTs based on EURORDIS Charter on Clinical Trials (CCT): promote signature by pharmaceutical Cies, and provide adequate staff and advisors to support the collaboration on specific CTs. f) Promote RD research policy and patient involvement in research. Page 5/10
6 COORDINATOR, LEADER CONTACT AND PARTNERS COORDINATOR (European Organisation for Rare Diseases) Plateforme Maladies Rares Rue Didot Paris France Project leader contact Name: Weiman Ariane opera@eurordis.org Phone: PARTNERS No partners related to the current project Page 6/10
7 OUTPUTS D04 - Electronic Newsletter and V.3 of EURORDIS website (EN) en_ps.pdf D01 - Activity Report OPERA (EN) s.pdf D B.1.b. Annexe 1.Report CNA meeting 13 May 2010 (EN) n_is.pdf D B.1.b. Annexe 2.Report CNA Meeting 12 December 2010 (EN) n_is.pdf D B.1.c. Annexe 1.3rd CEF Workshop - Page 7/10
8 Report (EN) n_is.pdf D B.1.c. Annexe 2.Support EF terms&conditions (EN) n_is.pdf D B.1.d. B.1.d. Annexe 1 (EN) n_is.pdf D03 - Update of EURORDIS RD community Database (EN) en_ps.pdf D05 - Summer School 2010 and online (EN) en_ps.pdf Page 8/10
9 D06 - Online patients and advocates community portal (EN) s.pdf D07 - Meetings of the Task Forces Orphan Drugs, DITA and Paediatrics (EN) s.pdf D08 - Participation in EMEA Committees (COMP, PDCO, CAT, PCWP) and update through the TAG (EN) s.pdf D09 - Rare Disease Day 2010 (EN) s.pdf Final Report (EN) Page 9/10
10 Powered by TCPDF ( pdf Page 10/10
Table Of Content. European Organisation for Rare Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...
Table Of Content European Organisation for Rare Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D04 - Electronic Newsletter (EN)... 7 D01 - Activity Report EURORDIS
More informationSTRATEGIC APPROACH & WORKPLAN 2007
Rare Diseases Europe STRATEGIC APPROACH 2007-2009 & WORKPLAN 2007 Paris, March 2007 www.eurordis.org Contents Our strategic approach 2007 2009 o Eurordis in 2010 o Strategic orientations o Priorities 2007-2009
More informationPHOTO. VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe
www.eurordis.org VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe Lucca ( Italy ) March 13-14, 2008 PHOTO www.eurordis.org
More informationTable Of Content. Policy Action and Information for Rare Diseases in Europe... 2 Summary... 3 Coordinator, Leader contact and partners...
Table Of Content Policy Action and Information for Rare Diseases in Europe... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Kontaktudvalget for Mindre Sygdoms-og handicapforeninger (KMS)...
More informationNORDIC CONFERENCE ON RARE DISEASES
www.eurordis.org NORDIC CONFERENCE ON RARE DISEASES 31 May 2012, Reykjavik, Iceland www.eurordis.org RARE DISEASES IN EUROPE Terkel ANDERSEN President of EURORDIS European Organisation for Rare Diseases
More informationTable Of Content. Annex 1: Conference report... 7 Annual project reports (URL)... 7 Original Full Information (Dec 2008)... 7.
Table Of Content Alcohol Policy Network in the Context of a Larger Europe: Bridging the Gap... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 Annex 1: Conference report... 7
More informationTable Of Content. OTH-01-5 years AIDS Action Europe (RU)... 6 OTH-02-5 years AIDS Action Europe (EN) Page 1/9
Table Of Content AIDS Action Europe: Public Policy Dialogue and Linking & Learning... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Outputs... 6 D01-01 - E-news AIDS Action Europe (EN)...
More informationThe basics a. Mission Statement (unchanged) eurordi s.org
The basics a. Mission Statement (unchanged) To build a strong pan-european community of patient organisations and people living with rare diseases, To be their voice at the European level And directly
More informationthe patients perspective and role of epags
Patients Registry in ERNs: the patients perspective and role of epags 5th International Summer School Rare Disease & Orphan Drug Registries VirginieBros-Facer, Research Infrastructure Project Manager 18
More informationTable Of Content. SSI_FY Summary... 3 Coordinator, Leader contact and partners... 7 Outputs... 8
Table Of Content SSI_FY2014... 2 Summary... 3 Coordinator, Leader contact and partners... 7 Outputs... 8 D01 - EuroMOMO system (EN)... 8 D02 - EuroMOMO website (EN)... 8 D03 - End of influenza season mortality
More informationTable Of Content. Page 1/14
Table Of Content Support to EATG in promoting UA in the New Member States and New Neighbourhood countries... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Outputs... 6 D09-03 - EATG Newsletter
More informationTransparency in drug regulatory decision making Why transparency? Birthe Byskov Holm, Rare Diseases Denmark Copenhagen October
Transparency in drug regulatory decision making Why transparency? Birthe Byskov Holm, Rare Diseases Denmark Copenhagen October 2. 2017. Transparency - A tool to drive change and innovasion? Breaking the
More informationTable Of Content. Outputs... 7
Table Of Content An EU Rare Diseases Registry for Wolfram Syndrome, Alstrom Syndrome and Bardet Biedl Syndrome... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Medical University of Lodz...
More informationDRAFT STRATEGIC APPROACH & ACTION PLAN For consultation at RDI Annual Meeting Edinburgh, Scotland May 25, 2016
DRAFT STRATEGIC APPROACH & ACTION PLAN 2016-2018 For consultation at RDI Annual Meeting Edinburgh, Scotland May 25, 2016 STRATEGIC PRIORITIES 1. Build a legitimate Global RD Patient Alliance to be the
More informationTable Of Content. Page 1/7
Table Of Content Closing the Gap - Reducing Premature Mortality. Baseline for Monitoring Health Evolution Following Enlargement... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Outputs...
More informationEuropean organisation for rare diseases. Activity Report. Paris, March
European organisation for rare diseases Activity Report > 2009 Paris, March 2010 www.eurordis.org European organisation for rare diseases 11 Health Policy & Health Care Services 7Advocacy 14 Research,
More informationTable Of Content. Page 1/8
Table Of Content 22nd Conference: Changing perceptions, practice and policy... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D04-00 - Programme and book of abstracts (EN)...
More informationrare diseases research through National Plans and Strategies
Recommendations to support rare diseases research through National Plans and Strategies Dr Domenica Taruscio EUROPLAN Coordinator Director of the Italian Centre for Rare Diseases, Italian National Institute
More informationEPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS
EPAG UPDATE Lenja Wiehe European Patient Advocacy Groups Manager, EURORDIS Patient Centre & Empowerment European Reference Networks (ERNs) created on founding principles of patient-centred care, patient
More informationTable Of Content. Outputs... 7
Table Of Content National policies for EHR implementation in the European area: social and organizational issues... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Foundation for Research
More informationDRAFT STRATEGIC APPROACH & ACTION PLAN For consultation at RDI Annual Meeting Edinburgh, Scotland May 25, 2016
DRAFT STRATEGIC APPROACH & ACTION PLAN 2016-2018 For consultation at RDI Annual Meeting Edinburgh, Scotland May 25, 2016 STRATEGIC PRIORITIES 1. Build a legi4mate Global RD Pa4ent Alliance to be the Voice
More informationTable Of Content. European Rare Kidney Diseases Reference Network... 2 Summary... 3 Work Package... 9
Table Of Content European Rare Kidney Diseases Reference Network... 2 Summary... 3 Work Package... 9 Network Management... 9 Promote cross-border expert healthcare... 9 Harmonize specialized care... 9
More informationTable Of Content. Outputs... 8
Table Of Content European Network of Reference for Rare Pediatric Neurological Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 5 University College London... 5 Univerzita Karlova
More informationTable Of Content. Information network on rare cancers... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...
Table Of Content Information network on rare cancers... 2 Summary... 3 Coordinator, Leader contact and partners... 5 National University Specialised Hospital for Active Treatment in Oncology - NOH... 5
More informationEUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs)
EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs) EUROPEAN REFERENCE NETWORKS FOR RARE DISEASES IN EUROPE: THE CONTEXT The need for European Reference Networks (ERNs) for rare
More informationESPA Directorate KPI Report: Quarter 1,
ESPA Directorate KPI : 2015 2016 Quarter 1, Compiled by ESPA Operations Manager The Key Performance Indicators (KPIs) detailed in this report give direction to the ESPA Directorate and its activities.
More informationParis, March 2011 European organisation for rare diseases. credit photo Boland. Activity Report.
Paris, March 2011 European organisation for rare diseases credit photo : @Luc Boland Activity Report > WORK PROGRAMME 2011 www.eurordis.org European organisation for rare diseases The Voice of Rare Disease
More informationTable Of Content. A European Network of Centres of Reference for Dysmorphology... 2 Summary... 3 Coordinator, Leader contact and partners...
Table Of Content A European Network of Centres of Reference for Dysmorphology... 2 Summary... 3 Coordinator, Leader contact and partners... 4 The Children's Memorial Health Institute IPCZD... 4 Katholieke
More informationPogány Gábor Ph.D. President of HUFERDIS Member of EUCERD and Orphanet International Advisory Board
Start by doing what's necessary then do what's possible and suddenly you are doing the impossible Saint Francis of Assisi Pogány Gábor Ph.D. President of HUFERDIS Member of EUCERD and Orphanet International
More informationTable Of Content. Smoking in movies: Impact on European youth and policy options... 2 Summary... 3 Coordinator, Leader contact and partners...
Table Of Content Smoking in movies: Impact on European youth and policy options... 2 Summary... 3 Coordinator, Leader contact and partners... 4 Medical Research Council (MRC)... 4 Radboud University Nijmegen...
More informationTable Of Content. Outputs... 7
Table Of Content Better control in paediatric and adolescent diabetes in the EU: working to create Centres of Reference... 2 Summary... 3 Coordinator, Leader contact and partners... 4 Hannover Medical
More informationEuropean Patients Academy on Therapeutic Innovation
European Patients Academy on Therapeutic Innovation http://www.patientsacademy.eu info@patientsacademy.eu The project is receiving support from the Innovative Medicines Initiative Joint Undertaking under
More informationACTION PLAN Adoption Annual Activity & Financial Report 2018 Adoption Work Programme: Action Plan & Budget 2019
ACTION PLAN 2019 1. STRENGTHEN RDI AS A WELL-GOVERNED AND SUSTAINABLE ORGANISATION Governance Legal incorporation in France, as Association Loi 1901, as an NGO, official publication based on Statutes Council
More informationTable Of Content. Outputs... 8
Table Of Content Developing a training and resource package for improving the sexual and reproductive health of people living with HIV/AIDS... 3 Summary... 4 Coordinator, Leader contact and partners...
More informationEUROPLAN National Conferences and Post-NCs activities in support to Member States
EUROPLAN National Conferences and Post-NCs activities in support to Member States Yann Le Cam, Ariane Weinman, Valentina Bottarelli EURORDIS Team Paris, France Brussels, Belgium EUROPLAN B Domenica Taruscio,
More informationTable Of Content. Outputs... 7
Table Of Content Surveillance System: Occurrence of Urinary Incontinence in Women as a Consequence of Inefficient or Inappropriate Obstetric Care... 2 Summary... 3 Coordinator, Leader contact and partners...
More informationTable Of Content. Outputs... 8
Table Of Content Coordinating a European initiative among national organizations for organ transplantation... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Pauls Stradins Clinical University
More informationTable Of Content. Outputs... 8
Table Of Content European registry and network for Intoxication type Metabolic Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants
More informationALCOHOL, TOBACCO & OTHER DRUGS COUNCIL TAS INC.
ALCOHOL, TOBACCO & OTHER DRUGS COUNCIL TAS INC. STRATEGIC PLAN 2015 2018 ABOUT THE ATDC The Alcohol, Tobacco and other Drugs Council Tas Inc. (ATDC) is the peak body representing the interests of community
More informationTABLE of Contents. EURORDIS in brief
TABLE of Contents 02 Foreword 06 EURORDIS in brief 07 Strategic approach 2015-2020 09 Activity Report 2017 HIGHLIGHTS 2017...11 PATIENT ADVOCACY...12 PATIENT EMPOWERMENT: BUILDING THE NETWORK & CAPACITIES..27
More informationTable Of Content. Alzheimer Europe Summary... 3 Work Package Coordinator, Leader contact and partners Outputs...
Table Of Content 2017... 2 Summary... 3 Work Package... 10 Increasing knowledge about current national dementia policies and strategies, in order to promote best practices and reduce existing inequalities
More informationPfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016
Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016 Please note that all information in this document is also disclosed in the overall report on Pfizer
More informationPROPOSED WORK PROGRAMME FOR THE CLEARING-HOUSE MECHANISM IN SUPPORT OF THE STRATEGIC PLAN FOR BIODIVERSITY Note by the Executive Secretary
CBD Distr. GENERAL UNEP/CBD/COP/11/31 30 July 2012 ORIGINAL: ENGLISH CONFERENCE OF THE PARTIES TO THE CONVENTION ON BIOLOGICAL DIVERSITY Eleventh meeting Hyderabad, India, 8 19 October 2012 Item 3.2 of
More informationRD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS
RD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS Stakeholder Group Interest in RD-Action Dissemination purpose Channels of Dissemination (WHO) (WHY) (WHY) (HOW) Partners of RD-Action & members
More informationTable Of Content. D Report on TB and HIV situation among vulnerable groups in the project area
Table Of Content TUBERCULOSIS EPIDEMIC AMONG VULNERABLE GROUPS... 3 Summary... 4 Coordinator, Leader contact and partners... 6 Сдружение "Доза обич"/ Dose of love Association... 6 Latvijas Tuberkulozes
More informationTalking With Each Other. Internal Communications Framework
Talking With Each Other Internal Communications Framework Approved August 9, 2017 The solutions to homelessness are as diverse as the people who experience it, and we all have a role to play in ending
More informationEuropean organisation for rare diseases Activity Report. The Voice of Rare Disease Patients in Europe. eurordis.org
European organisation for rare diseases Activity Report 2011 The Voice of Rare Disease Patients in Europe & WORKPLAN 2012 eurordis.org European 0rganisation for Rare Diseases Geschwisterliebe Felix, Tuberous
More informationSTRATEGIC PLAN 2014 to 2017
STRATEGIC PLAN 2014 to 2017 September 2014 1 P a g e KHNZ s STRATEGIC PLAN Contents Page 1. Introduction to the Strategic Plan 3 2. About Kidney Health New Zealand 4 3. The Challenges 6 4. Strategic Context
More informationRetina International General Assembly Auckland, New Zealand
Retina International General Assembly 2018 - Auckland, New Zealand Thursday, February 8th, 2018 Location: University of Auckland Business School Owen G Glenn Building, 12 Grafton Road, Auckland, 1010 Room:
More informationTuberous Sclerosis Australia Strategic Plan
Tuberous Sclerosis Australia Strategic Plan Last updated 27 November 2017 1. Our vision for the lives of people affected by tuberous sclerosis (TSC) 1. The impact of a diagnosis of TSC Tuberous Sclerosis
More informationEFSA and Member States
Scientific Cooperation between EFSA and Member States Taking Stock and Looking Ahead Committed to ensuring that Europe s food is safe Scientific Cooperation between EFSA and Member States Scientific cooperation
More informationAdding Value to the NHS, Health and Care, through Research Management, Support & Leadership
Invitation to Comment This new draft strategy has been developed to ensure that the Forum continues to thrive, that we meet the needs of the community over the next five years, and that by acting together
More informationFrequently asked questions
13 February 2017 EMA/527628/2011 Rev. 1 Directorate This document provides answers to the most frequently asked questions received by the European Medicines Agency (EMA).If the answer to your question
More information7 th European Conference on Rare Diseases & Orphan Products (ECRD 2014 Berlin) The Rare Disease Puzzle: Bringing the Picture to Life
Save the Date! 8 10 May 2014 Andel s Hotel, Berlin, Germany 2014 Berlin Brussels 23-25 May 2012 7 th European Conference on Rare Diseases & Orphan Products (ECRD 2014 Berlin) The Rare Disease Puzzle: Bringing
More informationTable Of Content. Outputs... 7
Table Of Content European Cooperation on Development and Implementation of Cancer Screening and Prevention Guidelines... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Scientific Institute
More informationTable Of Content. EUROCHIP-III "Common Actions"... 2 Summary... 3 Coordinator, Leader contact and partners Outputs... 7
Table Of Content EUROCHIP-III "Common Actions"... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Integraal Kankercentrum Noord-Nederland - IKN... 5 Suomen Syöpäyhdistys R.Y. (Cancer Society
More informationOperation of the European NGO Network for Smoking Prevention... 2 Summary... 3 Coordinator, Leader contact and partners... 5
Table Of Content Operation of the European NGO Network for Smoking Prevention... 2 Summary... 3 Coordinator, Leader contact and partners... 5 A.N.P.AS. Associazione Nazionale Pubbliche Assistenze... 5
More informationEURORDIS SUMMER SCHOOL EXPRESS YOURSELF!
EXPERT PATIENTS AND RESEARCHERS EURORDIS SUMMER SCHOOL EXPRESS YOURSELF! CASTELLDEFELS, BARCELONA, SPAIN JUNE 11-15, 2018 A capacity building programme for patient representatives & researchers on medicines
More informationEuropean Organisation for Rare Diseases EURORDIS Rare Diseases Europe
Yann LE CAM PERSONAL INFORMATION Work address: EURORDIS - 96 Rue Didot - 75014 Paris - France & EURORDIS University Foundation 11 rue d Egmont - 1000 Brussels - Belgium Telephone: +33 1 56 53 52 11 E-mail:
More informationRARE DISEASE DAY INFORMATION PACK 28 FEBRUARY 2017 PATIENT INVOLVEMENT: RESEARCH JOIN THE INTERNATIONAL CAMPAIGN TO RAISE AWARENESS FOR RARE DISEASES
INFORMATION PACK 28 FEBRUARY 2017 RARE DISEASE DAY PATIENT INVOLVEMENT: RESEARCH JOIN THE INTERNATIONAL CAMPAIGN TO RAISE AWARENESS FOR RARE DISEASES FOR MORE INFORMATION, CONTACT: RAREDISEASEDAY@EURORDIS.ORG
More informationTable Of Content. Outputs... 7
Table Of Content A framework for communicable disease surveillance, communication and training in Northern Europe, 2004-2006... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Swedish Institute
More informationThe HIV Prevention England programme: what s next? Cary James May 2016
The HIV Prevention England programme: what s next? Cary James May 2016 Summary Programme objectives Campaign evolution Sector development Structure and governance Support for HIV prevention system Communication
More informationComprehensive Cancer Control Technical Assistance Training and Communication Plan. PI: Mandi Pratt-Chapman, MA. Cooperative Agreement #1U38DP
Comprehensive Cancer Control Technical Assistance Training and Communication Plan PI: Mandi Pratt-Chapman, MA Cooperative Agreement #1U38DP004972-01 July 2014 Acknowledgement: This work was supported by
More informationThe European Medicines Agency (EMA)
The European Medicines Agency (EMA) Nathalie Bere and Maria Mavris Public Engagement Department EMA Training Day 21 November, 2017 An agency of the European Union What is the European Medicines Agency
More informationStudy protocol. Version 1 (06 April 2011) Ethics ref: R&D ref: UK CRC portfolio ID:
Identifying and prioritising important research questions for the treatment of eczema a collaborative partnership between patients, carers, clinicians and researchers Study protocol Version 1 (06 April
More informationPOSITION DESCRIPTION. Employment Status: Maternity Leave Contract 5 months (Jan-May 2018) PURPOSE OF POSITION DESCRIPTION
POSITION DESCRIPTION Position Title: Location: Research Coordinator Clinical Trials National Secretariat, Brisbane-based Employment Status: Maternity Leave Contract 5 months (Jan-May 2018) Reporting Relationships:
More information2013 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE
2013 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN CYPRUS This work was financed by the EUCERD Joint Action: Working for Rare Diseases
More informationMRCG Strategic Document
MRCG Strategic Document 2015-2016 The Medical Research Charities Group (MRCG) is an umbrella group of medical research and patient support charities that seeks to generate dynamic medical research in Ireland,
More informationWe are a network of successful REALTORS, advancing women as professionals and leaders in business, the industry and the communities we serve.
We are a network of successful REALTORS, advancing women as professionals and leaders in business, the industry and the communities we serve. Dear Business Professional: It is a pleasure to invite you
More informationPublic Engagement and Public and Patient Involvement. NIHR Newcastle Biomedical Research Centre and Biomedical Research Unit
Public Engagement and Public and Patient Involvement NIHR Newcastle Biomedical Research Centre and Biomedical Research Unit Our vision Patients, their carers and the wider public are a fundamental and
More informationDEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014
DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014 Karen Arts, Director Canadian Cancer Clinical Trial Network (3CTN) Chair of the Board of N2 Administrative Office: Lawson
More informationResearch for Development Impact Network
Research for Development Impact Network Mid-term Review of Research for Development Impact (RDI) Network Program Executive Summary and Management Response Submitted: 11 July 2017 This report has been prepared
More informationEURORDIS contribution to the Public Consultation Recast of the Medical Devices Directives
EURORDIS contribution to the Public Consultation Recast of the Medical Devices Directives EURORDIS - the European Organisation for Rare Diseases represents 341 rare disease organisations from 38 different
More informationEuropean organisation for rare diseases. Activity Report & WORKPLAN The Voice of Rare Disease Patients in Europe. eurordis.
European organisation for rare diseases Activity Report 2012 & WORKPLAN 2013 The Voice of Rare Disease Patients in Europe eurordis.org European 0rganisation for Rare Diseases Activity Report 2012 & WORKPLAN
More informationState of the Art of Rare Disease Activities in EU Member States and Other European Countries. Hungary Report
State of the Art of Rare Disease Activities in EU Member States and Other European Countries Definition of a Rare Disease Hungary Report Hungary has adopted the European Commission definition of a rare
More informationREGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC. second edition
REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC second edition World Health Organization 2014 The designations employed and the presentation of the material in
More informationRare Disease Day 2009
Rare Disease Day 2009 28 February 2009 INFOPACK Patient care, a public affair Merel, Epidermolysis Bullosa Winner of EURORDIS Photo Contest 2008 EURORDIS Plateforme Maladies Rares 102 rue Didot Paris 75014
More informationTable Of Content. Democracy, Cities & Drugs II... 3 Summary... 4 Coordinator, Leader contact and partners Outputs... 9
Table Of Content Democracy, Cities & Drugs II... 3 Summary... 4 Coordinator, Leader contact and partners... 6 Kur-Und Gesundheitszentrum KNAPPENHOF (from 12/03/2010)... 6 EUROPEAN TREATMENT CENTRES FOR
More information2008 Public Status Report on the Implementation of the European Risk Management Strategy. Executive Summary
European Medicines Agency London, 17 March 2009 Doc. Ref. EMEA/43556/2009 2008 Status Report on the Implementation of the European Risk Management Strategy Executive Summary The European Risk Management
More informationTable Of Content. Outputs... 9
Table Of Content European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Klinikum Dortmund ggmbh... 5 Uniwersytet
More informationUse of emerging technologies in provision of Cancer Information Services: an international snap shot
Use of emerging technologies in provision of Cancer Information Services: an international snap shot Dr Amanda Hordern PhD Director, Cancer Information and Support Service Satu Lipponen: Head of Communications
More informationTable Of Content. European Collaboration on Dementia... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...
Table Of Content European Collaboration on Dementia... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Associacao Portuguesa de Familiares e Amigos de Doentes de Alzheimer... 5 Universiteit
More informationThe European Medicines Agency (EMA)
The European Medicines Agency (EMA) Nathalie Bere Patient Relations Public Engagement Department EMA Training Day 29 November, 2016 An agency of the European Union What is the European Medicines Agency
More informationTable Of Content. Defining best practices in palliative care in Europe... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...
Table Of Content Defining best practices in palliative care in Europe... 2 Summary... 3 Coordinator, Leader contact and partners... 4 The University of Sheffield... 4 Fundacio Privat Institut d'investgadó
More informationPrevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Lucca, Italy March 2008
Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe Lucca, Italy 13-14 March 2008 Objectives Review activities, role, rationale and impact
More informationVolunteering in NHSScotland Developing and Sustaining Volunteering in NHSScotland
NG11-07 ing in NHSScotland Developing and Sustaining ing in NHSScotland Outcomes The National Group for ing in NHS Scotland agreed the outcomes below which formed the basis of the programme to develop
More informationTable Of Content. Outputs... 8
Table Of Content The PRES European Network of Registries for Autoinflammatoy Diseases in childhood.... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Assistance publique Hôpitaux de Paris-Centre
More informationWe are a network of successful REALTORS, advancing women as professionals and leaders in business, the industry and the communities we serve.
We are a network of successful REALTORS, advancing women as professionals and leaders in business, the industry and the communities we serve. Dear Business Professional: It is a pleasure to invite you
More informationStrategic Plan: Implementation Work Plan
Healthy Eating Active Living New Hampshire Strategic Plan: Implementation Work Plan July 1, 2011 June 30, Adopted: July 28, 2011 Goal One: Increase the number and effectiveness of community coalitions
More informationPRO-CHOICE PUBLIC EDUCATION PROJECT (PEP) STRATEGIC PLAN
PRO-CHOICE PUBLIC EDUCATION PROJECT (PEP) STRATEGIC PLAN 2010-2012 INTRODUCTION PEP entered 2009 with the energy and optimism that the 2008 elections had reawakened in communities and individuals across
More informationThe EU PIP - a step in Pediatric Drug Development. Thomas Severin Bonn,
The EU PIP - a step in Pediatric Drug Development Thomas Severin Bonn, 13.01.2009 Agenda Implications for Industry Company Preparation Time of PIP Submission Content of the PIP The PIP Process and first
More informationTable Of Content. Healthy Ageing Supported by Internet and the Community... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...
Table Of Content Healthy Ageing Supported by Internet and the Community... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Debreceni Egyetem, Tudományegyetemi Karok... 5 Universidad de Castilla-
More informationSection #3: Process of Change
Section #3: Process of Change This module will: Describe a model of change that supported the development and implementation of a palliative care program in long term care. Describe strategies that assisted
More informationCONGENITAL HEART PUBLIC HEALTH CONSORTIUM
CONGENITAL HEART PUBLIC HEALTH CONSORTIUM Impact and opportunity of a public health approach to congenital heart defects WHO WE ARE In 2009, various organizations across federal, state and local communities
More informationWebsite Briefing document for Multiple Sclerosis Society of Ireland.
Website Briefing document for Multiple Sclerosis Society of Ireland. Issued By: The Multiple Sclerosis Society of Ireland 80, Northumberland Rd Dublin 4 Tel: 01-678 1604 Email: thomasm@ms-society.ie Tender
More informationSTRATEGIC PLAN
STRATEGIC PLAN 2016 2020 Promoting and supporting excellence in research www.immunology.org BSI STRATEGY 2016 2020 EXECUTIVE SUMMARY OUR MISSION Our mission is to promote excellence in immunological research,
More informationTable Of Content. Outputs... 8
Table Of Content Operational knowledge to improve HIV early diagnosis and treatment among vulnerable groups in Europe... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Društvo Kulturno, informacijsko
More informationEuroHealthNet. EU Compass for Action on Mental health & Well-being. EUREGHA seminar: Mental Health in the Young 27 April 2017
EuroHealthNet EU Compass for Action on Mental health & Well-being EUREGHA seminar: Mental Health in the Young 27 April 2017 Claudia Marinetti Programme Manager About EuroHealthNet Objectives Reducing Health
More informationNSW Consumer Advisory Group Mental Health Inc
NSW Consumer Advisory Group Mental Health Inc Strategic Plan 2008 2010 We would like to thank Westwood Spice for guiding us through the process of developing this plan 501/80 William St Sydney NSW 2000
More informationWHY PATIENT ASSOCIATIONS SHOULD WORK INSIDE METABERN. MAURIZIO SCARPA, Anne-Sophie Lapointe (PhD) Coordinator MetabERN, epag PO
WHY PATIENT ASSOCIATIONS SHOULD WORK INSIDE METABERN MAURIZIO SCARPA, Anne-Sophie Lapointe (PhD) Coordinator MetabERN, epag PO 2 3 My conflict of interest! 4 VML s Core Values as many, many Pos. PRECISION
More information